Tenet Healthcare Corp. reported second-quarter earnings that beat expectations and prompted the hospital operator to raise its full-year outlook. Net income attributable to common shareholders climbed to $288 million, or $3.14 a share, from $259 million a year earlier. Adjusted diluted earnings per share jumped 74 % to $4.02, while operating revenue grew to $5.27 billion. Consolidated adjusted EBITDA rose 18.6 % to $1.121 billion, giving the Dallas-based company a 21.3 % margin. The Ambulatory Care division generated $498 million of adjusted EBITDA, an 11.4 % increase, aided by higher-acuity cases and acquisitions. On the back of the strong quarter, Tenet lifted its 2025 adjusted EBITDA forecast to $4.40 billion–$4.54 billion, roughly $395 million higher at the midpoint than its prior view. The board also authorized an additional $1.5 billion share-repurchase program, leaving $1.781 billion available. Shares of Tenet were up about 6 % in pre-market trading on the news.